XPENG INC. XPEV
XPENG INC. financials (annual)
Bars are annual figures from 2019 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $76.7B | $40.9B | $30.7B | $26.9B | $21.0B | $895.7M | $2.3B |
| Gross profit | $14.5B | $5.8B | $451.2M | $3.1B | $2.6B | $40.8M | -$558.1M |
| R&D expense | $9.5B | $6.5B | $5.3B | $5.2B | $4.1B | $264.5M | $2.1B |
| SG&A expense | $9.4B | $6.9B | $6.6B | $6.7B | $5.3B | $447.6M | $1.2B |
| Operating income | -$2.8B | -$6.7B | -$10.9B | -$8.7B | -$6.6B | -$658.0M | -$3.8B |
| Interest expense | $379.9M | $344.0M | $268.7M | $132.2M | $55.3M | $3.4M | $32.0M |
| Income tax | $13.6M | -$69.8M | $36.8M | $24.7M | $26.0M | $187,000 | $1,000 |
| Net income | -$1.1B | -$5.8B | -$10.4B | -$9.1B | -$4.9B | -$418.7M | -$3.7B |
| EPS (diluted) | $-0.60 | $-3.06 | $-5.96 | $5.34 | $-2.96 | $-6.48 | — |
| Operating cash flow | $8.3B | -$2.0B | $956.2M | -$8.2B | -$1.1B | -$21.4M | -$3.6B |
| Free cash flow | $5.1B | -$4.2B | -$1.1B | -$12.5B | -$3.4B | -$145.0M | -$5.4B |
| Cash & equivalents | $17.3B | $18.6B | $21.1B | $14.6B | $11.0B | $4.5B | $1.9B |
| Inventory | $10.4B | $5.6B | $5.5B | $4.5B | $2.7B | $205.8M | $454.1M |
| Total assets | $103.2B | $82.7B | $84.2B | $71.5B | $65.7B | $6.9B | $9.3B |
| Total liabilities | $72.8B | $51.4B | $47.8B | $34.6B | $23.5B | $1.6B | $6.4B |
| Shareholders' equity | $30.4B | $31.3B | $36.3B | $36.9B | $42.1B | $5.3B | -$6.8B |
Growth · year-over-year · Revenue CAGR 79.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue growth | +87.7% | +33.2% | +14.2% | +28.0% | +2243.3% | -61.4% | — |
| EPS growth | — | — | -211.6% | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.